NRG1 and cancer: PDGFRα, the primary receptor for PDGFC [30], was inhibited using a PDGFRα inhibitor, which effectively suppressed the ability of cancer cell-CM to promote NRG1 expression in fibroblasts (Figs. 5F and S4D).